Opinion

Video

Real World Perspectives: Outcomes for CAR T-cell Therapy in Relapsed/Refractory DLBCL

A review of real-world outcomes for CAR T-cell therapies in the relapsed/refractory setting from ASH 2024, comparing them to clinical trial results and addressing safety management concerns, toxicities, and prophylactic treatment options in practice.

Related Videos
5 experts are featured in this series
5 experts are featured in this series